GI Innovation, Inc. (KOSDAQ:358570)
South Korea · Delayed Price · Currency is KRW 16,680
-160 (-0.95%)
Aug 29, 2025, 12:40 PM KST
GI Innovation Revenue
GI Innovation had revenue of 212.27M KRW in the quarter ending March 31, 2025, with 774.19% growth. This brings the company's revenue in the last twelve months to 212.27M, down -96.03% year-over-year. In the year 2024, GI Innovation had annual revenue of 24.28M, down -99.54%.
Revenue (ttm)
212.27M
Revenue Growth
-96.03%
P/S Ratio
3,078.41
Revenue / Employee
n/a
Employees
n/a
Market Cap
1,040.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 24.28M | -5.29B | -99.54% |
| Dec 31, 2023 | 5.32B | 1.82B | 51.97% |
| Dec 31, 2022 | 3.50B | -2.10B | -37.50% |
| Dec 31, 2021 | 5.60B | -5.42B | -49.17% |
| Dec 31, 2020 | 11.02B | 7.50B | 213.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,031.69B |
| Celltrion | 3,748.95B |
| ALTEOGEN | 158.06B |
| Yuhan | 2,165.44B |
| SK Biopharmaceuticals | 620.28B |
| PharmaResearch | 392.31B |
| Peptron | 4.30B |
| LigaChem Biosciences | 146.42B |